Average Co-Inventor Count = 5.86
ph-index = 13
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Merck Frosst Canada, Inc. (14 from 212 patents)
2. Merck Frosst Canada & Co. (9 from 76 patents)
3. Axys Pharmaceuticals, Inc. (4 from 40 patents)
4. Other (2 from 832,843 patents)
5. Merck Sharp + Dohme Corp. (2 from 2,405 patents)
6. Merck Canada Inc. (2 from 40 patents)
7. Merck + Co., Inc. (1 from 4,770 patents)
8. The Royal Institution for the Advancement of Learning / Mcgill University (1 from 295 patents)
30 patents:
1. 10150787 - TC-PTP inhibitors as APC activators for immunotherapy
2. 10005804 - TC-PTP inhibitors as APC activators for immunotherapy
3. 9828399 - TC-PTP inhibitors as APC activators for immunotherapy
4. 8772336 - Cathepsin cysteine protease inhibitors
5. 8722734 - Composition for inhibition of cathepsin K
6. 8318748 - Cathepsin cysteine protease inhibitors
7. 7973037 - Cathepsin cysteine protease inhibitors
8. 7928091 - Cathepsin cysteine protease inhibitors
9. 7405229 - Cathepsin cysteine protease inhibitors
10. 7375134 - Cathepsin cysteine protease inhibitors
11. 7371747 - Cyanoalkylamino derivatives as protease inhibitors
12. 6525025 - Gamma-ketoacid dipeptides as inhibitors of caspase-3
13. 6225288 - Gamma-ketoacid dipeptides as inhibitors of caspase-3
14. 6222048 - Diaryl-2-(5H)-furanones as Cox-2 inhibitors
15. 6211210 - Diphenyl-1,2,3-thiadiazol-3-oxides, compositions and methods of use